2015 has been a remarkable year for pharmaceutical innovation. What would have been a dream (or perhaps a delusion) a few years ago has happened. Last year’s new drug approvals reached 51 (Figure 1), besting every year since 1950. This tally includes 45 drugs approved by FDA’s Center for Drug Evaluation and Research (CDER), and six recombinant therapies approved by the Center for Biologics Evaluation and Research (CBER). The latter include four drugs to treat blood coagulation disorders (e.g., hemophilia), a therapeutic vaccine for melanoma, and a preventive vaccine for meningococcal meningitis type B.
from Forbes - Leadership http://ift.tt/1JpsJbq
No comments:
Post a Comment